Papers - OHTAKE Tohru
-
Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis
Okano M, Oshi M, Butash AL, Katsuta E, Tachibana K, Saito K, Okayama H, Peng X, Yan L, Kono K, Ohtake T and Takabe K
Int. J. Mol. Sci. 2019.8
-
Prognostic impact of interleukin-6 and C-reactive protein on patients with breast cancer
Shimura T, Shibata M, Gonda K, Murakami Y, Noda M, Tachibana K, Abe N, Ohtake T
Oncology Letters 17 ( 6 ) 5139 - 5146 2019.2
-
Valvular heart disease as a possible predictor of trastuzumab‑induced cardiotoxicity in patients with breast cancer.
Sato A, Yoshihisa A, Miyata-tatsumi M, Oikawa M, Kobayashi A, Ishida T, Ohtake T, Takeishi Y
Molecular Clinical Oncology 10 37-42 2019.1
-
The 10-min holistic self-care for patients with breast cancer-related lymphedema: pilot randomized controlled study.
Arinaga Y, Piller N, Sato F, Ishida T, Ohtake T, Kikuchi K, Sato A, Tada H, Miyashita M
Tohoku J Exp Med 247 139 - 147 2019
-
Sato H, Ebi J, Tamaki T, Yukawa A, Nakajima M, Ohtake T, Suzuki Y
Journal of radiation research 59 ( 3 ) 298 - 302 2018.5（ ISSN:0449-3060 ）
-
Immunogenic tumor cell death induced by chemotherapy in patients with breast cancer and esophageal squamous cell carcinoma.
Aoto K, Mimura K, Okayama H, Saito M, Chida S, Noda M, Nakajima T, Saito K, Abe N, Ohki S, Ohtake T, Takenoshita S, Kono K.
Oncology Reports 39 151 - 159 2018
-
Decreased expression of CADM1 and CADM4 are associated with advanced stage breast cancer.
Saito M, Goto A, Abe N, Saito K, Maeda D, Ohtake T, Murakami Y, Takenoshita S.
Oncology Letters 15 2401 - 2406 2018
-
Augmentation og antibody-dependent cellular cytotoxity with defucosylated monoclonal antibodies in patients with GI-tract cancer.
Nakajima T, Okayama H, Ashizawa M, Noda M, Aoto K, Chida S, Saito M, Monma T, Ohki S, Shimura T, Shibata M, Ohtake T, Takenoshita S, Kono K.
Oncology Letters 15 ( 2 ) 2604-10 2018
-
Abscopal effect following radiation monotherapy in breast cancer: A case report.
Azami A, Suzuki N, Azami Y, Seto I, Sato A, Takano Y, Abe T, Taranishi Y, Tachibana K, Ohtake T.
Molecular and Clinical Oncology 9 283 - 286 2018
-
Expression profile of CADM1 and CADM4 in triple negative breast cancer with primary systemic therapy.
Kanke Y, Saito M, Abe N, Saito K, Goto A, Ohtake T, Murakami Y, Kono K.
Oncology Letters 2018
-
TBX19 is overexpressed in colorectal cancer and associated with lymph node metastasis.
Ando J, Saito M, Imai JI, Ito E, Yanagisawa Y, Honma R, Saito K, Tachibana K, Momma T, Ohki S, Ohtake T, Watanabe S, Waguri S, Kono K, Takenoshita S
Fukushima journal of medical science 63 ( 3 ) 141 - 151 2017.12（ ISSN:0016-2590 ）
-
Gonda K, Shibata M, Ohtake T, Matsumoto Y, Tachibana K, Abe N, Ohto H, Sakurai K, Takenoshita S
Oncology letters 14 ( 2 ) 1766 - 1774 2017.8（ ISSN:1792-1074 ）
-
Clinicopathological examination of dipeptidase 1 expression in colorectal cancer.
Tachibana K, Saito M, Imai J, Ito E, Yanagisawa Y, Honma R, Saito K, Ando J, Momma T, Ohki S, Ohtake T, Watanabe S, Waguri S and Takenoshita S.
Biomedical Report 2017
-
IL-17 and VEGF are increased and correlated to systemic inflammation, immune suppression, and malnutrition in patients with breast cancer.
Tachibana K, Shibata M, Gonda K, Matsumoto Y, Nakajima T, Abe N, Ohtake T, Ohto H, Kono K, Takenoshita S
European Journal of inflammation 2017
-
Arinaga Y., Sato F., Piller N., Kakamu T., Kikuchi K., Ohtake T., Sakuyama A., Yotsumoto F., Hori T., Sato N.
Lymphology 49 ( 2 ) 93 - 106 2016.1（ ISSN:00247766 ）
-
Clinicopathological significance of lymphangiogenesis detected by immunohistochemistry using D2-40 monoclonal antibody in breast cancer.
Abe N, Ohtake T, Saito K, Kumamoto K, Sugino T, Takenoshita S.
Fukushima J Med Sci 62 ( 1 ) 1 - 7 2016
-
Upregulated Annexin A1 promotes cellular invasion in triple-negative breast cancer.
Okano M, Kumamoto K, Saito M, Onozawa H, Saito K, Abe N, Ohtake T, Takenoshita S.
Oncol Rep 33 ( 3 ) 1064 - 1070 2015.3
-
Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
Tanaka M, Ichikawa-Tomikawa N, Shishito N, Nishiura K, Miura T, Hozumi A, Chiba H, Yoshida S, Ohtake T and Sugino T.
BMC Cancer 15 ( 53 ) 2015
-
Pathological aspects of the intraductal spread of breast cancer.
Ohtake T, Yasuda M, Ito J, Watanabe K, Gonda K, Abe N, Ishii M, Sato Y, Momma T, Takenoshita S.
Breast Cancer 20 ( 1 ) 34 - 40 2013
-
Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer.
Ohki S, Shibata M, Gonda K, Machida T, Shimura T, Nakamura I, Ohtake T, Koyama Y, Suzuki S, Ohto H, Takenoshita S.
Oncology Reports 28 ( 2 ) 453 - 8 2012